Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03869346
Other study ID # NAOOP
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 10, 2019
Est. completion date May 20, 2021

Study information

Verified date September 2019
Source Peking University People's Hospital
Contact Qi Yan, MD
Phone 13811319638
Email yanqi04@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Purpose: This study aimed to investigate the impact of CYP3A4*1G genetic polymorphism on non-analgesic effects of fentanyl in Chinese Han patients. Methods: 200 patients receiving elective surgery under general anesthesia were recruited into this study. Venous blood was withdrawn for genotyping of CYP3A4*1G before operation. Fentanyl 2 µg/kg was administered preoperatively. Bispectral Index (BIS), Respiratory rate(RR), etc at Tb (entering room), T0 (drug administration), T1 (2min), T2 (4min), T3(6min), T4(8min), T5(10min), T6(20min) were recorded.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date May 20, 2021
Est. primary completion date March 10, 2021
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists Grade?-II,Patients undergo elective surgery for benign Reproductive diseases (including laparoscopic ovarian cyst removal, laparoscopic tubal ligation, laparoscopic tubal drainage, laparoscopic salpingoplasty, etc.) or breast disease.

- Aged 18-45 years

- Body Mass Index 18-25kg/m2,body weight 40-65 kilograms

- Agreed to participate the research

Exclusion Criteria:

- Difficult airway

- upper respiratory tract infection within 2 weeks

- history of allergy or long-term use of propofol and opioids

- self-rating anxiety scale before operation indicates anxiety

- pregnancy or lactation.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Peking University People's Hospital Beijing Beijing

Sponsors (2)

Lead Sponsor Collaborator
Peking University People's Hospital Yichang Humanwell Pharmaceutical Co.,Ltd

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary bispectral index bispectral index(BIS): assessing the sedation, placed on the patient's forehead, BIS values 0-100, and the higher score means patients are more conscious 20 min after administration
Primary respiratory rate Number of breaths per minute 20 min after administration
Primary CYP3A4*1G Polymorphism The patients were classified by genotype including wild-type homozygote (CYP3A4*1/*1, GG), mutant heterozygote (CYP3A4*1/*1G, GA), and mutant homozygote (CYP3A4*1G/*1G, AA). 1 week after operation
See also
  Status Clinical Trial Phase
Completed NCT02840006 - Spinal Anesthesia Associated With General Anesthesia in Coronary Artery Bypass Phase 4
Recruiting NCT06210061 - Propofol-Fentanyl-Dexmedetomidine and Propofol-Fentanyl-Sevoflurane Anesthesia for Major Spine Surgery Under Somato Sensory- and Motor- Evoked Potential Monitoring N/A
Completed NCT06052111 - Dexmedetomidine vs Fentanyl on Time to Extubation in Patients Undergoing Laparoscopic Sleeve Gastrectomy N/A
Recruiting NCT05243940 - Opioid-free Anesthesia in Thyroidectomies N/A
Completed NCT03607110 - Comparison of Efficacy of Anesthesia Administered by Endoscopist or Anesthesiologist on Colonoscopy
Recruiting NCT06386783 - Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects Phase 3
Completed NCT04397406 - Dexmedetomidine or Fentanyl as Additives to Epidural Levobupivacaine in Painless Labor Phase 4
Not yet recruiting NCT05985850 - Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy Phase 2
Withdrawn NCT02985177 - A RCT of a Combination of Analgesics for Pain Management in Children With a Suspected Fracture Phase 4
Completed NCT03901716 - Comparison of Sufentanil, Fentanyl and Remifentanil in Combination With Midazolam During Bronchoscopy Under Conscious Sedation Phase 4
Recruiting NCT06051227 - Fentanyl OR Esketamine for Traumatic PAIN (FORE-PAIN) Trial Phase 3
Completed NCT04597320 - Esketamine Sedation and Fentanyl Sedation in Pediatric Dental Patients Phase 4
Active, not recruiting NCT03198208 - Intraoperative Fentanyl Dose on Respiratory Complications N/A
Recruiting NCT05805241 - Pharmacogenetics Analysis of Fentanyl Administered in Newborns
Completed NCT02031016 - Remifentanil vs Fentanyl During Cardiac Surgery and Chronic Thoracic Pain Phase 4
Withdrawn NCT01488149 - Intrapartum Epidural Fentanyl and Breast-feeding in the Immediate Postpartum Period: a Prospective Cohort Study
Terminated NCT03948464 - Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder Phase 3
Recruiting NCT05145543 - Effect of Topically Administered Levobupivacaine- Fentanyl Versus Levobupivacaine- Dexamethasone Combination in the Control of Pain After Endoscopic Sinus Surgery Phase 2/Phase 3
Completed NCT04971759 - Dexmedetomidine to Levobupivacaine for Transversus Abdominis Plane Block in Elderly Patients Undergoing Inguinal Hernia Repair Surgery Phase 2/Phase 3
Recruiting NCT05367336 - Platelet Reactivity With Fentanyl, Morphine, or no Narcotic Early Phase 1